RSD Medlex Pharmaceuticals Private Limited
About RSD Medlex Pharmaceuticals Private Limited
Data last updated:
RSD Medlex Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 18 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2019PTC346159. Its GSTIN is 07AAJCR4324C1ZN (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Devender Bhardwaj (Managing Director) and Seema Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. – 85 Indra Park, Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.1 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹11,949 (net margin -0.6%) and EBITDA of -₹10,465 (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
RSD Medlex Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. – 85 Indra Park, Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
To see the full contact details of RSD Medlex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of RSD Medlex Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of RSD Medlex Pharmaceuticals Private Limited, buy the company report.
Financials of RSD Medlex Pharmaceuticals Private Limited
FY 2025 filings availableRSD Medlex Pharmaceuticals Private Limited reported revenue of ₹20.1 Lakh (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 80%. EBITDA fell 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10,465 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11,949 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RSD Medlex Pharmaceuticals Private Limited, buy the company report.
Board of directors of RSD Medlex Pharmaceuticals Private Limited
RSD Medlex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Bhardwaj | Director | 06 Oct 2020 | 6 Years 1 Months | Current |
| Devender Bhardwaj | Managing Director | 18 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving RSD Medlex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RSD Medlex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
RSD Medlex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCR4324C1ZN | Delhi | Active | 23 Nov 2020 |
To see the full GST registrations and return filing status of RSD Medlex Pharmaceuticals Private Limited, buy the company report.
Recent activity
RSD Medlex Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Sagar ceased to be Director on 07 Oct 2020.
Frequently asked questions
RSD Medlex Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 18 February 2019 (7+ years old) and is registered under CIN U24110DL2019PTC346159.
RSD Medlex Pharmaceuticals has 2 current directors:
- Devender Bhardwaj - Managing Director
- Seema Bhardwaj - Director
The latest financial statements of RSD Medlex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of RSD Medlex Pharmaceuticals is 07AAJCR4324C1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of RSD Medlex Pharmaceuticals is U24110DL2019PTC346159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RSD Medlex Pharmaceuticals was incorporated on 18 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Sagar ceased to be Director on 07 Oct 2020. Seema Bhardwaj was appointed as Director on 06 Oct 2020. Ravinder ceased to be Director on 01 May 2019. RSD Medlex Pharmaceuticals has 4 board changes on record in total.
The registered office of RSD Medlex Pharmaceuticals is at H. No. – 85 Indra Park, Uttam Nagar, New Delhi, Delhi, India – 110059.
RSD Medlex Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
The compliance status of RSD Medlex Pharmaceuticals is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
